BioMed Realty acquires 154K-SF office property in Seattle


SEATTLE, WA – BioMed Realty has acquired a 154,000 square foot lab-ready building in Seattle, WA.

Located in the South Lake Union neighborhood, the property at 1101 Westlake is currently fully leased to Meta.

“This acquisition marks an important milestone for BioMed’s growing portfolio in Seattle while underscoring the continued return of the technology industry to the office,” said Jon Bergschneider, President of West Coast Markets at BioMed Realty. “The acquisition of this outstanding, 100% leased property will allow us to support the city’s innovation ecosystem and talent-rich community now and into the future.”

The transaction is BioMed Realty’s second acquisition in Seattle this quarter.

The company now owns 1.4 million square feet of existing office and laboratory space in the city, including its flagship Dexter Yard project. The Company’s development pipeline is 1.2 million square feet, including recent acquisitions of Denny Park South and the T6 Innovation Center at 200 Taylor Ave. N

“Seattle remains one of the nation’s premier centers for life science and technology, fueled by a highly skilled workforce, a growing population and leading research institutions,” said Tim Schoen, CEO of BioMed Realty. “BioMed is proud to provide life science companies and technology leaders with a quality infrastructure to continue collaborating and innovating in a thriving ecosystem.”

Within Seattle, the Company leases space to life science and technology companies such as Seattle Children’s Hospital, Novo Nordisk Research Center Seattle Inc., Omeros Corp., InBios International Inc., Lyell Immunopharma Inc., Shape Therapeutics Inc. and Inc .


Comments are closed.